Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT03241420

Utility of Lung Clearance Index Score as a Noninvasive Marker of Small Airways Disease

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
600 (estimated)
Sponsor
National Jewish Health · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

To determine the utility and sensitivity of the lung clearance index (LCI) technique as a marker of small airways disease in adults with chronic lung conditions compared to healthy adults, adjusting for age, sex and smoking status.

Detailed description

Target Population and Enrollment. The study will recruit and consent 300 patients from our Occupational Medicine and Interstitial Lung/Rheumatology Clinics at National Jewish Health who have been referred for evaluation of chronic lung conditions. The healthy control group will comprise 300 volunteers who are at least 18 years of age, have no history of pre-existing lung disease, and report no respiratory illness in the four weeks preceding enrollment. Inclusion criteria for the group with chronic lung disease will include physician diagnosis of a chronic lung condition (e.g. bronchiolitis, pulmonary fibrosis, asthma, coal mine dust lung disease, asbestosis), and age ≥18 years. Exclusion criteria will include recent myocardial infarction, stroke, eye surgery, chest/abdominal surgery (within past month), known thoracic, aortic, or cerebral aneurysm, or uncontrolled hypertension. Study participation will consist of one visit that will last between 90-120 minutes. The chronic lung disease group will fill out the informed consent and complete both LCI testing and spirometry. The healthy control group will complete informed consent, a brief questionnaire, LCI testing, and spirometry.

Conditions

Interventions

TypeNameDescription
DEVICElung clearance index (LCI)Determine the utility and sensitivity of the lung clearance index (LCI) technique as a marker of lung injury/small airways disease in adults with chronic lung conditions compared to health adults, adjusting for age, sex, and smoking status.

Timeline

Start date
2017-04-24
Primary completion
2030-12-01
Completion
2030-12-01
First posted
2017-08-07
Last updated
2026-04-15

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03241420. Inclusion in this directory is not an endorsement.